Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mircera vs Epoetin for Anemia Correction in Dialysis (AMICUS)
NCT00077597Phase 3Completed
- Sponsor
- Roche
- Start
- Feb 2004
- Primary completion
- Jun 2006
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 13
01
Overview
A Phase 3 trial of methoxy polyethylene glycol-epoetin beta in Anemia In Chronic Kidney Disease, sponsored by Roche. Started Feb 2004; status: completed.
02
Drugs
methoxy polyethylene glycol-epoetin beta
03
Conditions
Anemia In Chronic Kidney Disease
Beyond the preview
Go deeper on NCT00077597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00077597.